Positron emission tomography: poor sensitivity for occult tonsillar cancer

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 28, Issue 3, 2007, Pages 153-157

  Nabili, Vishad ^a   Zaia, Brita ^a   Blackwell, Keith E ^a   Head, Christian S ^a   Grabski, Karsten ^a   Sercarz, Joel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TONSIL CANCER;

AGED; CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TONSILLAR NEOPLASMS;

EID: 34247860560     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2006.08.001     Document Type: Article

References (21)

1. Million R.R., Cassisi N.J., and Mancuso A.A. Management of head and neck cancer: a multidisciplinary approach (1994), Lippincott Williams & Wilkins, Philadelphia 311-320
2. Fu K.K. Neck node metastases from unknown primary. Front Radiat Ther Oncol 28 (1994) 66-78
3. Greven K.M., Keyes J.W., Williams D.W., et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-d-glucose. Cancer 86 1 (1999) 114-118
4. McGuirt W.F., Greven K., Williams D., et al. PET scanning in head and neck oncology: a review. Head Neck 20 3 (1998) 208-215
5. Nolop K.B., Rhodes C.G., Brudin L.H., et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60 11 (1987) 2682-2689
6. Braams J.W., Pruim J., Kole A.C., et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 26 2 (1997) 112-115
7. Paulus P., Sambon A., Vivegnis D., et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 108 10 (1998) 1578-1583
8. Bailet J.W., Sercarz J.A., Abemayor E., et al. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 105 2 (1995) 135-139
9. Anzai Y., Carroll W.R., Quint D.J., et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-d-glucose PET and MR imaging diagnoses. Radiology 200 1 (1996) 135-141
10. Kresnik E., Mikosch P., Gallowitsch H.J., et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28 7 (2001) 816-821
11. Rege S., Maass A., Chaiken L., et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73 12 (1994) 3047-3058
12. Assar O.S., Fischbein N.J., Caputo G.R., et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 210 1 (1999) 177-181
13. Mukherji S.K., Drane W.E., Mancuso A.A., et al. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-d-glucose SPECT. Radiology 199 3 (1996) 761-766
14. Hanasono M.M., Kunda L.D., Segall G.M., et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 109 (1999) 880-885
15. Safa A.A., Tran L.M., Rege S., et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am 5 4 (1999) 214-218
16. Nakamoto Y., Sakamoto S., Okada T., et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 234 3 (2005) 879-885
17. Wong W.L., and Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 15 8 (2003) 461-466
18. Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
19. Miller F.R., Hussey D., Beeram M., et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 131 (2005) 626-629
20. Watanabe K., Nomori H., Ohtsuka T., et al. False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3cm in size. Chest 117 3 (2000) 773-778
21. Detterbeck F.C., Falen S., Rivera M.P., et al. Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Ann Thorac Cardiovasc Surg 9 6 (2003) 397-400